Skip to content

Medical-device intelligence

QDQ: Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer

FDA product code QDQ: Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QDQ
FDA device name
Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer
Device class
2
Regulation number
892.2090
Medical specialty
Radiology
Review panel
RA

FDA definition

A radiological computer assisted detection and diagnostic software for suspected lesions is an image processing device intended to aid in the detection, localization, and characterization of lesions suspicious for cancer on acquired medical images (e.g., mammography , MR, CT, ultrasound, radiography). The device detects, identifies and characterizes lesions suspicious for cancer based on features or information extracted from the images, and may provide information about the presence, location, and characteristics of the lesion to the user. Primary diagnostic and patient management decisions are made by the clinical user.
Explore radiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

41 clearance records and 0 recall records in the covered releases, across 16 source company names and 1 product codes. Dated history runs from Nov 21, 2018 to Nov 6, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202610
March 202610
April 202620
May 202600
June 202620
July 202610
August 202620
September 202610
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

41 matching records
Device / recordCompany in FDA recordSourceSource date
CadAI-B DxK263749 · QDQBeamWorks, Inc.510(k)Nov 6, 2026FDA decision date
qCT Lung (v1.0)K261517 · QDQQure.Ai Technologies Pvt. , Ltd.510(k)Sep 14, 2026FDA decision date
Transpara (2.1.0)K260898 · QDQScreenpoint Medical B.V.510(k)Aug 14, 2026FDA decision date
CadAI-B DxK260086 · QDQBeamWorks, Inc.510(k)Aug 12, 2026FDA decision date
See-Mode Augmented Reporting Tool, Breast (SMART-B)K260303 · QDQSee-Mode Technologies Pty, Ltd.510(k)Jul 28, 2026FDA decision date
MammoScreen® (5)K260714 · QDQTherapixel510(k)Jun 26, 2026FDA decision date
Saige-DxK253825 · QDQDeepHealth, Inc.510(k)Jun 15, 2026FDA decision date
DeepHealth ProstateAIK253682 · QDQQuantib B.V.510(k)Apr 29, 2026FDA decision date
Lunit INSIGHT MMG (v1.1.10)K260320 · QDQLunit, Inc.510(k)Apr 23, 2026FDA decision date
Lunit INSIGHT DBT (V1.2)K253796 · QDQLunit, Inc.510(k)Mar 26, 2026FDA decision date
Median LCS (internal name) / eyonis LCS (trade name) (1.0)K251474 · QDQMedian Technologies510(k)Feb 6, 2026FDA decision date
Saige-DxK251873 · QDQDeepHealth, Inc.510(k)Aug 11, 2025FDA decision date
Genius AI Detection 2.0K243341 · QDQHologic, Inc.510(k)Jul 31, 2025FDA decision date
MammoScreen® (4)K243679 · QDQTherapixel510(k)Jul 3, 2025FDA decision date
QP-Prostate® CADK242683 · QDQQuibim S.L.510(k)Mar 18, 2025FDA decision date
Prostate MR AI (VA10A)K241770 · QDQSiemens Healthcare GmbH510(k)Mar 5, 2025FDA decision date
Saige-Dx (3.1.0)K243688 · QDQDeepHealth, Inc.510(k)Dec 19, 2024FDA decision date
Transpara (2.1.0)K241831 · QDQScreenpoint Medical B.V.510(k)Nov 25, 2024FDA decision date
Saige-DxK241747 · QDQDeepHealth, Inc.510(k)Nov 18, 2024FDA decision date
ProFound Detection (V4.0)K240417 · QDQIcad, Inc.510(k)Nov 8, 2024FDA decision date
Lunit INSIGHT DBT v1.1K242652 · QDQLunit, Inc.510(k)Oct 4, 2024FDA decision date
See-Mode Augmented Reporting Tool, Thyroid (SMART-T)K240697 · QDQSee-Mode Technologies Pte, Ltd.510(k)Sep 9, 2024FDA decision date
MammoScreen® (3)K240301 · QDQTherapixel510(k)Aug 1, 2024FDA decision date
Lunit INSIGHT DBTK231470 · QDQLunit, Inc.510(k)Nov 6, 2023FDA decision date
Genius AI Detection 2.0 with CC-MLO CorrelationK230096 · QDQHologic, Inc.510(k)May 23, 2023FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗